SlideShare a Scribd company logo
Dr. Laxmi Shrikhande MD; FICOG; FICMCH;FICMU
▪ Director-Shrikhande Fertility Centre, Nagpur
▪ Senior Vice President FOGSI 2012
▪ Associate member RCOG, London
▪ Member of European Society of Human Reproduction
▪ Received Bharat excellence Award for contribution to women’s health
▪ Chairperson HIV Committee FOGSI 2009-12
▪ Received best FOGSI committee award
▪ National Editor-The Journal of OB / GY of India
▪ Vice Chairperson Elect Indian College of OB/GY
▪ Publications-Thirteen National & seven International
▪ Editor-FOGSI Focus on HIV in women
▪ Editor-FOGSI Focus on SUI- Myths & Facts
▪ Presented Papers at FIGO,SAFOG,AOFOG, IFFS
Luteal phase support in IUI
and ART
Dr Laxmi Shrikhande
Director-Shrikhande Hospital &
Research Centre, INDIA
“When a thing ceases to be a subject of
controversy, it ceases to be a subject
of interest.”
William Hazlitt (1778–1830), English essayist
• Since the first formal description of LPD in 1949 as a
possible cause of infertility and recurrent
miscarriage by Jones,
• innumerable investigations have been undertaken in
an effort to verify its existence or to characterize its
pathophysiology, diagnosis, and treatment.
Jones GES: Some newer aspects of management of infertility. JAMA 141:1123, 1949
The consensus of the literature is that LPD does exist
and that its cause is multifactorial-
• abnormal folliculogenesis,
• inadequate LH surge,
• inadequate secretion of progesterone by the
corpus luteum,
• aberrant end-organ response by the
endometrium
Scope
• Is there any need for support in natural cycle /
IUI / IVF cycles ?
• What to give ?
• When to give ?
• What dose?
• When to stop ?
Luteal phase in a natural cycle
• Between ovulation and either
pregnancy / menses
• LH as the hormone to
support corpus luteum and
stimulate progesterone
production
• In ovulatory women, 92% of
cycles show normal luteal
function, and luteal support is
unnecessary (Rosenberg et al.,
1980).
Natural cycle IUI
• Donor Inseminations
• Cervical factor infertility
• Mild/Moderate male factor infertility
Luteal Phase support will unnecessarily increase the cost
of the cycle without increasing the pregnancy rate.Thus
not recommended
What happens to Luteal phase in stimulated
cycles
▪ Multiple follicles of different size might ovulate at different
times, expanding the fertilization window.
▪ Thus, both oestradiol and progesterone, after multiple
ovulation is expected to be significantly higher
(Macklon and Fauser, 2000).
▪ These high concentrations may not only influence the
receptivity of the endometrium, but may also cause luteal
insufficiency and early luteolysis
(Erdem et al., 2008).
CC - Stimulated Cycles
Some authors reported luteal phase
inadequacy in up to 50% of clomiphene citrate
induced cycles in anovulatory women
[Cook et al.,1984,Keenan et al.,1989]
CC - Stimulated Cycles
▪ 400 women analysed
▪ No difference observed in ongoing pregnancy between
patients who did, or did not, receive vaginal
progesterone as luteal support [8.7% (17/196) versus
9.3% (19/204)
▪ Thus routine supplementation of the luteal phase with
vaginal progesterone does not seem to improve
pregnancy rates in normo-ovulatory women stimulated
with clomiphene citrate for IUI
Paul devroy, Human reproduction, vol 25, issue 10. pg 2501-2506
Studies favoring the luteal phase support in IUI
• Montville et al -Fertil Steril. 2010
• Erdem et al – Fertil Steril. 2009
• Cohlen review - Reprod Biomed Online.
2009
Studies not favoring luteal phase support in IUI
• Ebrahimy M.- 12th International Congress of
Gynecology and Obstetrics 2010.
• Kyrou D - Hum Reprod. 2010
• Bibi Shahnaz Aali, Iran J Reprod Med. Apr 2013
• Romero Nieto MI , Gynecol Endocrinol.2014
Luteal phase support after IUI
Conclusion
➢ Progesterone luteal phase support may be of benefit to
patients undergoing ovulation induction with gonadotropins
in IUIcycles.
➢ Progesterone support did not benefit patients undergoing
ovulation induction with CC, suggesting a potential
difference in endogenous luteal phase function depending
on the method of ovulation induction.
Hill MJ Fertil Steril. 2013- a systematic review and meta-analysis.
LPS in IUI cycles
• Shortened luteal phase in 20% of stimulated cycles for
ovulation induction using FSH (Olson et al., 1983).
• In a recent meta-analysis (Hill et al., FS, 2013) of 5 trials
involving 1,938 cycles in 1,298 patients, LPS with P
improves success.
• Improvement seen in FSH cycles only but not in CC-
induced cycles.
OR (95% CI)
Clinincal pregnancy 1.47 (1.15-1.98)
Live birth 2.11 (1.21-3.67)
Luteal phase defect in IVF
Reasons
1.Supra-physiological steroid concentrations
secreted by multiple corpora lutea directly inhibit
LH release (Fauser and Devroey, 2003)
2.HCG for the final oocyte maturation suppresses
LH production (Miyake et al., 1979)
Luteal phase defect in IVF
3. GnRH agonist or antagonist for downregulation
prevents LH rise in the luteal phase
4. Removal of large quantities of granulosa cells
during oocyte retrieval
• hCG or progesterone improved pregnancy rates IVF
cycles using GnRH agonist
• OHSS in 5% of cycles with hCG
• Conclusion: Routine use of luteal phase support in
IVF cycles using GnRH agonist
Meta-analysis of 18 trials
• 385 women were randomized into 3 groups
hCG TUGOR ET (D3)
No. of patients 130 128 127
Ongoing
pregnancy rate
20.8% 22.7% 23.6%
IVF
Period
Egg
retrieva
l
Embryo
transfer Pregnancy tes
Ovarian stimulation
Antagonist
GnRH agonist
LUTEAL PHASE SUPPORT
What? How long? When?
LPS in ART
1. Human chorionic gonadotrophin (hCG)
2. Progesterone: oral, intramuscular, vaginal
3. Progesterone and oestradiol
4. hCG and progesterone
5. Progesterone and GnRH agonist
hCG Vs Progesterone
• No significant difference found between P and
hCG or between P and P plus hCG in terms of
pregnancy or miscarriage rates
• Risk of OHSS significantly higher with treatments
involving hCG than with P alone
Progesterone Vs HCG
• Consensus opinion in favor of
Progesterone
❖Once pregnancy is established
– Supplemental hCG is not beneficial
Progesterone
• Different routes of administration
❑Oral, intramuscular or vaginal
Oral progesterone
• Reduced implantation rates when compared with
hCG, IM and vaginal progesterone
▪ Poor bioavailability due to rapid hepatic metabolism
(Maxson et al., 1984)
▪ Failure to induce uniform secretory changes in
endometrium (Devroey et al., 1989; Critchley et al., 1990)
• Metabolites induce significant sedative and hypnotic
effects (Arafat et al., 1988)
Vaginal progesterone
• Easy to administer
• Avoids liver first-pass metabolism
• No systemic side-effects
• Higher endometrial tissue level despite low serum
level due to ‘first uterine pass effect’
• Similar pregnancy rate as intramuscular
progesterone
Vaginal progesterone
• Associated with vaginal discharge and perineal
irritation
▪ tablets: 6%
▪ gelatin capsules: 0-14%
▪ suppositories: 25-30%
▪ bioadhesive gel: 17%
• Affect patients’ comfort and compliance during
the IVF treatment
Intramuscular progesterone
• Uncomfortable daily injections
• Trained medical personnel
• Allergic reactions to the oil vehicle and marked
inflammation at the injection site, resulting in
redness, pain and even sterile abscess formation
Dydrogesterone
• It is structurally and pharmacologically
similar to natural progesterone, has
good oral bioavailability
• has a good safety and tolerability profile
• has no androgenic effects on the fetus,
• 1,373 infertile women undergoing IVF randomized
into micronized P gel (Crinone 90mg daily), P capsule
(Utrogestan 200mg tds), and oral dydrogesterone
(Duphason 10mg bd)
• Comparable PR and miscarriage rates
Oral Vaginal gel Vaginal capsule
Clinical PR
at 7 weeks
121/422 (28.7%) 138/482 (28.6%) 104/459 (22.7%)
Miscarriage
rate
14/121 (11.6%) 18/138 (13.0%) 19/104 (18.3%)
Dydrogesterone / vaginal progesterone
Comparison of oral dydrogesterone with suppository
vaginal progesterone for luteal-phase support in in
vitro fertilization (IVF): A randomized clinical trial.
Salehpour S, Iran J Reprod Med. 2013
Conclusion - Oral dydrogesterone is as effective as
vaginal progesterone for luteal-phase support in
women undergoing IVF.
GnRH agonist in luteal phase -IUI
▪ GnRH agonist was recently suggested as a novel luteal-
phase support that may act at different levels, including
the pituitary gonadotrophs, the endometrium and the
embryo itself
▪ Regimens for IUI :
▪ single dose triptorelin 0.1 mg 6 days after ovulation
▪ Three doses of lupride 1 mg sc 6 days after ovualation
GnRH agonist in luteal phase-IVF
Evaluation of the impact of gonadotropin-releasing
hormone agonist as an adjuvant in luteal-phase support
on IVF outcome.
Conclusion - Three 1 mg doses of Lupride administration 6
days after oocyte retrieval in the long protocol cycles does not
result in an increase in ongoing pregnancy rates.
Inamdar and A Majumdar.J Hum Reprod Sci. 2012.
GnRH agonist as luteal phase support in IVF
• GnRH-a can collaborate in the corpus luteum
function, acting directly on the endometrium via local
receptors, a direct effect on the embryos or
combination.
• GnRH-a administration can improve clinical outcomes
after ICSI.
• Premature to recommend the use of GnRH-a in the
luteal phase because of heterogeneity among trials
Role of oestrogen in IUI for luteal support
• The role of oestrogen along with
progesterone in the luteal phase appears to
be only in those cases where GnRH agonist
was used instead of hCG to trigger ovulation
Estradiol as luteal phase support-IVF
1. The use of estradiol for luteal phase support in IVF /
ICSI cycles: a systematic review and meta-analysis.
Gelbaya TA, Fertil Steril. 2008
conclusion - The addition of E(2) to P4 for luteal phase support in
IVF/ICSI cycles has no beneficial effect on pregnancy rates
2. Luteal phase support with estrogen in addition to
progesterone increases pregnancy rates in IVF cycles with
poor response to gonadotropins.Kutlusoy F , Gynecol
Endocrinol. 2014
LPS in natural cycle FET
• Controversial
1. Retrospective study: no effect on pregnancy rate
following vaginal P in hCG-induced natural FET
cycles (Kyrou et al., 2010)
2. RCT: significantly higher live birth rate when vaginal
P was given in natural FET cycles (30% Vs 20%); no
difference in clinical PR and miscarriage rate
(Bjuresten et al., 2011)
• Before 1st July 2009, 2 doses of 1500 IU hCG given on
the day of FET and 6 days after the transfer.
• Such practice was stopped after 1st July 2009.
With hCG Without hCG
Clinical PR 53/205 (25.9%) 59/203 (21.1%)
Miscarriage rate 12/66 (18.2%) 12/75 (16.0%)
When to stop ?
600 mg of progesterone starting on the day
of ET for 14 days after ET
150 women did NOT receive P
for another 3 weeks (Study
group)
150 women received P for another 3
weeks (Control group)
Delivery rate
+ve hCG
• Prolongation of P in the early pregnancy (up to 7
weeks of gestation) has no effect on the
miscarriage and delivery rates.
• P can be safely withdrawn after a positive hCG test
Study Group Control group
Ongoing preg. 133 (88.7) 139 (90.8)
Delivery 118 (78.7) 126 (82.4)
Biochemical 10 (6.7) 7 (4.0)
Abortion 22 (14.6) 18 (11.8)
F&S, 2010
No difference in ongoing pregnancy and miscarriage
rates on early P cessation
F&S, 2012
F&S, 2010
Duration of LPS in IVF
Authors Protocol Study Gp Control Gp
Andersen 2002 Vaginal P
Livebirth
LPS till 7 wks
78.7%
LPS till PT+ve (4 wks)
82.4%
Aboulghar 2008 Vaginal or IM P
Miscarriage
LPS till 10 wks
4.6%
LPS till USS (7 wks)
4.8%
Goudge 2010 IM P
Livebirth
LPS till 8 wks
52.0%
LPS till PT+ve (4 wks)
49.0%
Kyrou 2011 Vaginal P
Ongoing
LPS till 7 wks
82.0%
LPS till PT+ve (4 wks)
73.0%
Kohls 2012 Vaginal P
Ongoing
LPS till 8 wks
73.0%
LPS till USS (5 wks)
75.0%
Conclusion
• Prevalence of a luteal phase defect in natural
cycles is about 8.1% (Rosenberg et al., 1980).
• In these cases LPS is controversial
• CC stimulated cycles do not disturb the
luteal phase, however there is an urgent need
for prospective randomised trials.
• HMG/rec-FSH with GnRH agonist and
antagonist cycles must be supplemented.
Conclusion
• IVF
✓vaginal P alone for about 2 weeks from day of
hCG, TUGOR or ET
• FET in natural cycles
✓Controversial
• IUI
✓Vaginal progesterone for 2 weeks
Dr. Laxmi Shrikhande
Shrikhande IVF & Surrogacy Center
Ph-96234 59766 / shrikhandedrlaxmi@gmail.com
'Spiritual blossoming' simply means
blossoming in life in all dimensions.
Being happy, at ease with yourself
and with everybody around you.
Sri Sri Ravi Shankar
The Art of Living

More Related Content

What's hot

Fresh Vs Frozen Embryo Transfer What’s The Current Practice? : Dr Sharda Jain
Fresh Vs Frozen Embryo Transfer What’s The Current Practice? : Dr Sharda Jain Fresh Vs Frozen Embryo Transfer What’s The Current Practice? : Dr Sharda Jain
Fresh Vs Frozen Embryo Transfer What’s The Current Practice? : Dr Sharda Jain
Lifecare Centre
 
Luteal phase support in ART Cases Dr Sharda Jain
Luteal phase  support in ART Cases Dr Sharda Jain Luteal phase  support in ART Cases Dr Sharda Jain
Luteal phase support in ART Cases Dr Sharda Jain
Lifecare Centre
 
Progestin-primed ovarian stimulation (PPOS) is a NEW DAW...
Progestin-primed ovarian stimulation (PPOS)                      is a NEW DAW...Progestin-primed ovarian stimulation (PPOS)                      is a NEW DAW...
Progestin-primed ovarian stimulation (PPOS) is a NEW DAW...
Lifecare Centre
 
Thin Endometrium
Thin EndometriumThin Endometrium
Thin Endometrium
Sujoy Dasgupta
 
Controlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVFControlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVF
Aboubakr Elnashar
 
AN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMENAN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMEN
Vasundhara Hospital & Fertility Research Centre Jaipur
 
Management of Poor Responders
Management of Poor RespondersManagement of Poor Responders
Management of Poor RespondersSandro Esteves
 
Difficult Cases in IUI
Difficult Cases in IUIDifficult Cases in IUI
Difficult Cases in IUI
Sujoy Dasgupta
 
Optimizing IUI Outcome
Optimizing IUI OutcomeOptimizing IUI Outcome
Optimizing IUI Outcome
Dr.Laxmi Agrawal Shrikhande
 
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil BharatiOvulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Bharati Dhorepatil
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation induction
sunitafeme
 
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilPCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
Bharati Dhorepatil
 
Endometriosis and art
Endometriosis and artEndometriosis and art
Endometriosis and art
NARENDRA MALHOTRA
 
Ovulation induction in IUI
Ovulation induction in IUIOvulation induction in IUI
Ovulation induction in IUI
Poonam Loomba
 
Monitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharMonitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr Elnashar
Aboubakr Elnashar
 
EMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROMEEMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROME
Aboubakr Elnashar
 
Luteal Phase Support in ART
Luteal Phase Support in ARTLuteal Phase Support in ART
Luteal Phase Support in ART
Dr. Sherif Anis Hebisha
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Lifecare Centre
 

What's hot (20)

Fresh Vs Frozen Embryo Transfer What’s The Current Practice? : Dr Sharda Jain
Fresh Vs Frozen Embryo Transfer What’s The Current Practice? : Dr Sharda Jain Fresh Vs Frozen Embryo Transfer What’s The Current Practice? : Dr Sharda Jain
Fresh Vs Frozen Embryo Transfer What’s The Current Practice? : Dr Sharda Jain
 
Luteal phase support in ART Cases Dr Sharda Jain
Luteal phase  support in ART Cases Dr Sharda Jain Luteal phase  support in ART Cases Dr Sharda Jain
Luteal phase support in ART Cases Dr Sharda Jain
 
Progestin-primed ovarian stimulation (PPOS) is a NEW DAW...
Progestin-primed ovarian stimulation (PPOS)                      is a NEW DAW...Progestin-primed ovarian stimulation (PPOS)                      is a NEW DAW...
Progestin-primed ovarian stimulation (PPOS) is a NEW DAW...
 
Thin Endometrium
Thin EndometriumThin Endometrium
Thin Endometrium
 
Controlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVFControlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVF
 
AN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMENAN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMEN
 
Management of Poor Responders
Management of Poor RespondersManagement of Poor Responders
Management of Poor Responders
 
Difficult Cases in IUI
Difficult Cases in IUIDifficult Cases in IUI
Difficult Cases in IUI
 
Optimizing IUI Outcome
Optimizing IUI OutcomeOptimizing IUI Outcome
Optimizing IUI Outcome
 
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil BharatiOvulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
Ovulation Stimulation Protocols for IUI - Dr Dhorepatil Bharati
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
Fet endometrial preparation
Fet endometrial preparationFet endometrial preparation
Fet endometrial preparation
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation induction
 
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilPCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
 
Endometriosis and art
Endometriosis and artEndometriosis and art
Endometriosis and art
 
Ovulation induction in IUI
Ovulation induction in IUIOvulation induction in IUI
Ovulation induction in IUI
 
Monitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharMonitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr Elnashar
 
EMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROMEEMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROME
 
Luteal Phase Support in ART
Luteal Phase Support in ARTLuteal Phase Support in ART
Luteal Phase Support in ART
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
 

Similar to Luteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVF

Evidence Based Approach to Luteal Phase Support in IVF Cycles
Evidence Based Approach to Luteal Phase Support in IVF CyclesEvidence Based Approach to Luteal Phase Support in IVF Cycles
Evidence Based Approach to Luteal Phase Support in IVF Cycles
Dr. Snehal Dhobale Kohale
 
Luteal phase support in art - revisited
Luteal phase support in art  - revisitedLuteal phase support in art  - revisited
Luteal phase support in art - revisitedLifecare Centre
 
Luteal phase support in art - revisited
Luteal phase support in art  - revisitedLuteal phase support in art  - revisited
Luteal phase support in art - revisitedLifecare Centre
 
Luteaal phase support lifecare centre
Luteaal phase support lifecare centreLuteaal phase support lifecare centre
Luteaal phase support lifecare centreLifecare Centre
 
Luteal phase support in assisted reproductive technology (ART)
Luteal phase support in assisted reproductive technology (ART)Luteal phase support in assisted reproductive technology (ART)
Luteal phase support in assisted reproductive technology (ART)
Dr. Sunita Chandra
 
Treatment of decreased ovarian reserve
Treatment of decreased ovarian reserveTreatment of decreased ovarian reserve
Treatment of decreased ovarian reserve
Dr.Laxmi Agrawal Shrikhande
 
Progesteron & Estrogen - Clinical Applications - Dr Dhorepatil Bharati
Progesteron & Estrogen - Clinical Applications - Dr Dhorepatil BharatiProgesteron & Estrogen - Clinical Applications - Dr Dhorepatil Bharati
Progesteron & Estrogen - Clinical Applications - Dr Dhorepatil Bharati
Bharati Dhorepatil
 
4S1XaeX0ffffffdggggggggggPmQ56CgK99.pptx
4S1XaeX0ffffffdggggggggggPmQ56CgK99.pptx4S1XaeX0ffffffdggggggggggPmQ56CgK99.pptx
4S1XaeX0ffffffdggggggggggPmQ56CgK99.pptx
IslamSaeed19
 
Ovulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUIOvulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUI
Bharati Dhorepatil
 
Luteal Phase Insufficiency.pptx
Luteal Phase Insufficiency.pptxLuteal Phase Insufficiency.pptx
Luteal Phase Insufficiency.pptx
Raju Nair
 
Progesterone and reproduction: Concepts
Progesterone and reproduction: ConceptsProgesterone and reproduction: Concepts
Progesterone and reproduction: Concepts
Mahmoud Abdel-Aleem
 
Any day start.pptx
Any day start.pptxAny day start.pptx
Any day start.pptx
Raju Nair
 
Subfertility
SubfertilitySubfertility
Subfertility
Sujoy Dasgupta
 
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive GuideOptimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Dr.Laxmi Agrawal Shrikhande
 
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
Candido Tomás
 
Luteal Phase Support In IVF
Luteal Phase Support In IVFLuteal Phase Support In IVF
Luteal Phase Support In IVF
Abdulmagid Sarhan
 
Iui - newer concepts
Iui  - newer conceptsIui  - newer concepts
Iui - newer concepts
Dr Sachin Dalal
 
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal  Dr. Jyoti Bh...Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal  Dr. Jyoti Bh...
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...
Lifecare Centre
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation induction
nermine amin
 
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVFCURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
Aboubakr Elnashar
 

Similar to Luteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVF (20)

Evidence Based Approach to Luteal Phase Support in IVF Cycles
Evidence Based Approach to Luteal Phase Support in IVF CyclesEvidence Based Approach to Luteal Phase Support in IVF Cycles
Evidence Based Approach to Luteal Phase Support in IVF Cycles
 
Luteal phase support in art - revisited
Luteal phase support in art  - revisitedLuteal phase support in art  - revisited
Luteal phase support in art - revisited
 
Luteal phase support in art - revisited
Luteal phase support in art  - revisitedLuteal phase support in art  - revisited
Luteal phase support in art - revisited
 
Luteaal phase support lifecare centre
Luteaal phase support lifecare centreLuteaal phase support lifecare centre
Luteaal phase support lifecare centre
 
Luteal phase support in assisted reproductive technology (ART)
Luteal phase support in assisted reproductive technology (ART)Luteal phase support in assisted reproductive technology (ART)
Luteal phase support in assisted reproductive technology (ART)
 
Treatment of decreased ovarian reserve
Treatment of decreased ovarian reserveTreatment of decreased ovarian reserve
Treatment of decreased ovarian reserve
 
Progesteron & Estrogen - Clinical Applications - Dr Dhorepatil Bharati
Progesteron & Estrogen - Clinical Applications - Dr Dhorepatil BharatiProgesteron & Estrogen - Clinical Applications - Dr Dhorepatil Bharati
Progesteron & Estrogen - Clinical Applications - Dr Dhorepatil Bharati
 
4S1XaeX0ffffffdggggggggggPmQ56CgK99.pptx
4S1XaeX0ffffffdggggggggggPmQ56CgK99.pptx4S1XaeX0ffffffdggggggggggPmQ56CgK99.pptx
4S1XaeX0ffffffdggggggggggPmQ56CgK99.pptx
 
Ovulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUIOvulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUI
 
Luteal Phase Insufficiency.pptx
Luteal Phase Insufficiency.pptxLuteal Phase Insufficiency.pptx
Luteal Phase Insufficiency.pptx
 
Progesterone and reproduction: Concepts
Progesterone and reproduction: ConceptsProgesterone and reproduction: Concepts
Progesterone and reproduction: Concepts
 
Any day start.pptx
Any day start.pptxAny day start.pptx
Any day start.pptx
 
Subfertility
SubfertilitySubfertility
Subfertility
 
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive GuideOptimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
 
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
 
Luteal Phase Support In IVF
Luteal Phase Support In IVFLuteal Phase Support In IVF
Luteal Phase Support In IVF
 
Iui - newer concepts
Iui  - newer conceptsIui  - newer concepts
Iui - newer concepts
 
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal  Dr. Jyoti Bh...Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal  Dr. Jyoti Bh...
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation induction
 
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVFCURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
 

More from Dr.Laxmi Agrawal Shrikhande

5 Essential Steps for Menopause Hormone Therapy
5 Essential Steps for Menopause Hormone Therapy5 Essential Steps for Menopause Hormone Therapy
5 Essential Steps for Menopause Hormone Therapy
Dr.Laxmi Agrawal Shrikhande
 
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and ManagementUnderstanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Dr.Laxmi Agrawal Shrikhande
 
Understanding Late Onset Menopause: Navigating Reproductive Changes with Age
Understanding Late Onset Menopause: Navigating Reproductive Changes with AgeUnderstanding Late Onset Menopause: Navigating Reproductive Changes with Age
Understanding Late Onset Menopause: Navigating Reproductive Changes with Age
Dr.Laxmi Agrawal Shrikhande
 
Urinary Tract Infection in Pregnancy.pptx
Urinary Tract Infection in Pregnancy.pptxUrinary Tract Infection in Pregnancy.pptx
Urinary Tract Infection in Pregnancy.pptx
Dr.Laxmi Agrawal Shrikhande
 
Unlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception CareUnlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception Care
Dr.Laxmi Agrawal Shrikhande
 
Nourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at MidlifeNourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at Midlife
Dr.Laxmi Agrawal Shrikhande
 
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Dr.Laxmi Agrawal Shrikhande
 
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi ShrikhandeOptimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Dr.Laxmi Agrawal Shrikhande
 
GDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptxGDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptx
Dr.Laxmi Agrawal Shrikhande
 
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
Dr.Laxmi Agrawal Shrikhande
 
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained InfertilityCritical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
Dr.Laxmi Agrawal Shrikhande
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
Dr.Laxmi Agrawal Shrikhande
 
Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1
Dr.Laxmi Agrawal Shrikhande
 
Non Specific Musculoskeletal Pain
Non Specific Musculoskeletal PainNon Specific Musculoskeletal Pain
Non Specific Musculoskeletal Pain
Dr.Laxmi Agrawal Shrikhande
 
Preview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal PainPreview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal Pain
Dr.Laxmi Agrawal Shrikhande
 
Contraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptxContraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptx
Dr.Laxmi Agrawal Shrikhande
 
Preview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we goingPreview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we going
Dr.Laxmi Agrawal Shrikhande
 
Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
Dr.Laxmi Agrawal Shrikhande
 
Oral health & Pregnancy.pptx
Oral health & Pregnancy.pptxOral health & Pregnancy.pptx
Oral health & Pregnancy.pptx
Dr.Laxmi Agrawal Shrikhande
 
AMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptxAMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptx
Dr.Laxmi Agrawal Shrikhande
 

More from Dr.Laxmi Agrawal Shrikhande (20)

5 Essential Steps for Menopause Hormone Therapy
5 Essential Steps for Menopause Hormone Therapy5 Essential Steps for Menopause Hormone Therapy
5 Essential Steps for Menopause Hormone Therapy
 
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and ManagementUnderstanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
 
Understanding Late Onset Menopause: Navigating Reproductive Changes with Age
Understanding Late Onset Menopause: Navigating Reproductive Changes with AgeUnderstanding Late Onset Menopause: Navigating Reproductive Changes with Age
Understanding Late Onset Menopause: Navigating Reproductive Changes with Age
 
Urinary Tract Infection in Pregnancy.pptx
Urinary Tract Infection in Pregnancy.pptxUrinary Tract Infection in Pregnancy.pptx
Urinary Tract Infection in Pregnancy.pptx
 
Unlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception CareUnlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception Care
 
Nourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at MidlifeNourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at Midlife
 
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
 
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi ShrikhandeOptimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
 
GDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptxGDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptx
 
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
 
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained InfertilityCritical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
 
Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1
 
Non Specific Musculoskeletal Pain
Non Specific Musculoskeletal PainNon Specific Musculoskeletal Pain
Non Specific Musculoskeletal Pain
 
Preview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal PainPreview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal Pain
 
Contraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptxContraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptx
 
Preview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we goingPreview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we going
 
Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
 
Oral health & Pregnancy.pptx
Oral health & Pregnancy.pptxOral health & Pregnancy.pptx
Oral health & Pregnancy.pptx
 
AMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptxAMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptx
 

Recently uploaded

POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
ranishasharma67
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cell
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
KRISTELLEGAMBOA2
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
Nguyễn Thị Vân Anh
 
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
Nguyễn Thị Vân Anh
 

Recently uploaded (20)

POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
 
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
 

Luteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVF

  • 1. Dr. Laxmi Shrikhande MD; FICOG; FICMCH;FICMU ▪ Director-Shrikhande Fertility Centre, Nagpur ▪ Senior Vice President FOGSI 2012 ▪ Associate member RCOG, London ▪ Member of European Society of Human Reproduction ▪ Received Bharat excellence Award for contribution to women’s health ▪ Chairperson HIV Committee FOGSI 2009-12 ▪ Received best FOGSI committee award ▪ National Editor-The Journal of OB / GY of India ▪ Vice Chairperson Elect Indian College of OB/GY ▪ Publications-Thirteen National & seven International ▪ Editor-FOGSI Focus on HIV in women ▪ Editor-FOGSI Focus on SUI- Myths & Facts ▪ Presented Papers at FIGO,SAFOG,AOFOG, IFFS
  • 2. Luteal phase support in IUI and ART Dr Laxmi Shrikhande Director-Shrikhande Hospital & Research Centre, INDIA
  • 3. “When a thing ceases to be a subject of controversy, it ceases to be a subject of interest.” William Hazlitt (1778–1830), English essayist
  • 4. • Since the first formal description of LPD in 1949 as a possible cause of infertility and recurrent miscarriage by Jones, • innumerable investigations have been undertaken in an effort to verify its existence or to characterize its pathophysiology, diagnosis, and treatment. Jones GES: Some newer aspects of management of infertility. JAMA 141:1123, 1949
  • 5. The consensus of the literature is that LPD does exist and that its cause is multifactorial- • abnormal folliculogenesis, • inadequate LH surge, • inadequate secretion of progesterone by the corpus luteum, • aberrant end-organ response by the endometrium
  • 6. Scope • Is there any need for support in natural cycle / IUI / IVF cycles ? • What to give ? • When to give ? • What dose? • When to stop ?
  • 7. Luteal phase in a natural cycle • Between ovulation and either pregnancy / menses • LH as the hormone to support corpus luteum and stimulate progesterone production • In ovulatory women, 92% of cycles show normal luteal function, and luteal support is unnecessary (Rosenberg et al., 1980).
  • 8. Natural cycle IUI • Donor Inseminations • Cervical factor infertility • Mild/Moderate male factor infertility Luteal Phase support will unnecessarily increase the cost of the cycle without increasing the pregnancy rate.Thus not recommended
  • 9. What happens to Luteal phase in stimulated cycles ▪ Multiple follicles of different size might ovulate at different times, expanding the fertilization window. ▪ Thus, both oestradiol and progesterone, after multiple ovulation is expected to be significantly higher (Macklon and Fauser, 2000). ▪ These high concentrations may not only influence the receptivity of the endometrium, but may also cause luteal insufficiency and early luteolysis (Erdem et al., 2008).
  • 10. CC - Stimulated Cycles Some authors reported luteal phase inadequacy in up to 50% of clomiphene citrate induced cycles in anovulatory women [Cook et al.,1984,Keenan et al.,1989]
  • 11. CC - Stimulated Cycles ▪ 400 women analysed ▪ No difference observed in ongoing pregnancy between patients who did, or did not, receive vaginal progesterone as luteal support [8.7% (17/196) versus 9.3% (19/204) ▪ Thus routine supplementation of the luteal phase with vaginal progesterone does not seem to improve pregnancy rates in normo-ovulatory women stimulated with clomiphene citrate for IUI Paul devroy, Human reproduction, vol 25, issue 10. pg 2501-2506
  • 12. Studies favoring the luteal phase support in IUI • Montville et al -Fertil Steril. 2010 • Erdem et al – Fertil Steril. 2009 • Cohlen review - Reprod Biomed Online. 2009
  • 13. Studies not favoring luteal phase support in IUI • Ebrahimy M.- 12th International Congress of Gynecology and Obstetrics 2010. • Kyrou D - Hum Reprod. 2010 • Bibi Shahnaz Aali, Iran J Reprod Med. Apr 2013 • Romero Nieto MI , Gynecol Endocrinol.2014
  • 14. Luteal phase support after IUI Conclusion ➢ Progesterone luteal phase support may be of benefit to patients undergoing ovulation induction with gonadotropins in IUIcycles. ➢ Progesterone support did not benefit patients undergoing ovulation induction with CC, suggesting a potential difference in endogenous luteal phase function depending on the method of ovulation induction. Hill MJ Fertil Steril. 2013- a systematic review and meta-analysis.
  • 15. LPS in IUI cycles • Shortened luteal phase in 20% of stimulated cycles for ovulation induction using FSH (Olson et al., 1983). • In a recent meta-analysis (Hill et al., FS, 2013) of 5 trials involving 1,938 cycles in 1,298 patients, LPS with P improves success. • Improvement seen in FSH cycles only but not in CC- induced cycles. OR (95% CI) Clinincal pregnancy 1.47 (1.15-1.98) Live birth 2.11 (1.21-3.67)
  • 16. Luteal phase defect in IVF Reasons 1.Supra-physiological steroid concentrations secreted by multiple corpora lutea directly inhibit LH release (Fauser and Devroey, 2003) 2.HCG for the final oocyte maturation suppresses LH production (Miyake et al., 1979)
  • 17. Luteal phase defect in IVF 3. GnRH agonist or antagonist for downregulation prevents LH rise in the luteal phase 4. Removal of large quantities of granulosa cells during oocyte retrieval
  • 18. • hCG or progesterone improved pregnancy rates IVF cycles using GnRH agonist • OHSS in 5% of cycles with hCG • Conclusion: Routine use of luteal phase support in IVF cycles using GnRH agonist Meta-analysis of 18 trials
  • 19. • 385 women were randomized into 3 groups hCG TUGOR ET (D3) No. of patients 130 128 127 Ongoing pregnancy rate 20.8% 22.7% 23.6%
  • 20. IVF Period Egg retrieva l Embryo transfer Pregnancy tes Ovarian stimulation Antagonist GnRH agonist LUTEAL PHASE SUPPORT What? How long? When?
  • 21. LPS in ART 1. Human chorionic gonadotrophin (hCG) 2. Progesterone: oral, intramuscular, vaginal 3. Progesterone and oestradiol 4. hCG and progesterone 5. Progesterone and GnRH agonist
  • 22. hCG Vs Progesterone • No significant difference found between P and hCG or between P and P plus hCG in terms of pregnancy or miscarriage rates • Risk of OHSS significantly higher with treatments involving hCG than with P alone
  • 23. Progesterone Vs HCG • Consensus opinion in favor of Progesterone ❖Once pregnancy is established – Supplemental hCG is not beneficial
  • 24. Progesterone • Different routes of administration ❑Oral, intramuscular or vaginal
  • 25. Oral progesterone • Reduced implantation rates when compared with hCG, IM and vaginal progesterone ▪ Poor bioavailability due to rapid hepatic metabolism (Maxson et al., 1984) ▪ Failure to induce uniform secretory changes in endometrium (Devroey et al., 1989; Critchley et al., 1990) • Metabolites induce significant sedative and hypnotic effects (Arafat et al., 1988)
  • 26. Vaginal progesterone • Easy to administer • Avoids liver first-pass metabolism • No systemic side-effects • Higher endometrial tissue level despite low serum level due to ‘first uterine pass effect’ • Similar pregnancy rate as intramuscular progesterone
  • 27. Vaginal progesterone • Associated with vaginal discharge and perineal irritation ▪ tablets: 6% ▪ gelatin capsules: 0-14% ▪ suppositories: 25-30% ▪ bioadhesive gel: 17% • Affect patients’ comfort and compliance during the IVF treatment
  • 28. Intramuscular progesterone • Uncomfortable daily injections • Trained medical personnel • Allergic reactions to the oil vehicle and marked inflammation at the injection site, resulting in redness, pain and even sterile abscess formation
  • 29. Dydrogesterone • It is structurally and pharmacologically similar to natural progesterone, has good oral bioavailability • has a good safety and tolerability profile • has no androgenic effects on the fetus,
  • 30. • 1,373 infertile women undergoing IVF randomized into micronized P gel (Crinone 90mg daily), P capsule (Utrogestan 200mg tds), and oral dydrogesterone (Duphason 10mg bd) • Comparable PR and miscarriage rates Oral Vaginal gel Vaginal capsule Clinical PR at 7 weeks 121/422 (28.7%) 138/482 (28.6%) 104/459 (22.7%) Miscarriage rate 14/121 (11.6%) 18/138 (13.0%) 19/104 (18.3%)
  • 31. Dydrogesterone / vaginal progesterone Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial. Salehpour S, Iran J Reprod Med. 2013 Conclusion - Oral dydrogesterone is as effective as vaginal progesterone for luteal-phase support in women undergoing IVF.
  • 32. GnRH agonist in luteal phase -IUI ▪ GnRH agonist was recently suggested as a novel luteal- phase support that may act at different levels, including the pituitary gonadotrophs, the endometrium and the embryo itself ▪ Regimens for IUI : ▪ single dose triptorelin 0.1 mg 6 days after ovulation ▪ Three doses of lupride 1 mg sc 6 days after ovualation
  • 33. GnRH agonist in luteal phase-IVF Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome. Conclusion - Three 1 mg doses of Lupride administration 6 days after oocyte retrieval in the long protocol cycles does not result in an increase in ongoing pregnancy rates. Inamdar and A Majumdar.J Hum Reprod Sci. 2012.
  • 34. GnRH agonist as luteal phase support in IVF
  • 35. • GnRH-a can collaborate in the corpus luteum function, acting directly on the endometrium via local receptors, a direct effect on the embryos or combination. • GnRH-a administration can improve clinical outcomes after ICSI. • Premature to recommend the use of GnRH-a in the luteal phase because of heterogeneity among trials
  • 36. Role of oestrogen in IUI for luteal support • The role of oestrogen along with progesterone in the luteal phase appears to be only in those cases where GnRH agonist was used instead of hCG to trigger ovulation
  • 37. Estradiol as luteal phase support-IVF 1. The use of estradiol for luteal phase support in IVF / ICSI cycles: a systematic review and meta-analysis. Gelbaya TA, Fertil Steril. 2008 conclusion - The addition of E(2) to P4 for luteal phase support in IVF/ICSI cycles has no beneficial effect on pregnancy rates 2. Luteal phase support with estrogen in addition to progesterone increases pregnancy rates in IVF cycles with poor response to gonadotropins.Kutlusoy F , Gynecol Endocrinol. 2014
  • 38. LPS in natural cycle FET • Controversial 1. Retrospective study: no effect on pregnancy rate following vaginal P in hCG-induced natural FET cycles (Kyrou et al., 2010) 2. RCT: significantly higher live birth rate when vaginal P was given in natural FET cycles (30% Vs 20%); no difference in clinical PR and miscarriage rate (Bjuresten et al., 2011)
  • 39. • Before 1st July 2009, 2 doses of 1500 IU hCG given on the day of FET and 6 days after the transfer. • Such practice was stopped after 1st July 2009. With hCG Without hCG Clinical PR 53/205 (25.9%) 59/203 (21.1%) Miscarriage rate 12/66 (18.2%) 12/75 (16.0%)
  • 41. 600 mg of progesterone starting on the day of ET for 14 days after ET 150 women did NOT receive P for another 3 weeks (Study group) 150 women received P for another 3 weeks (Control group) Delivery rate +ve hCG
  • 42. • Prolongation of P in the early pregnancy (up to 7 weeks of gestation) has no effect on the miscarriage and delivery rates. • P can be safely withdrawn after a positive hCG test Study Group Control group Ongoing preg. 133 (88.7) 139 (90.8) Delivery 118 (78.7) 126 (82.4) Biochemical 10 (6.7) 7 (4.0) Abortion 22 (14.6) 18 (11.8)
  • 43. F&S, 2010 No difference in ongoing pregnancy and miscarriage rates on early P cessation F&S, 2012 F&S, 2010
  • 44. Duration of LPS in IVF Authors Protocol Study Gp Control Gp Andersen 2002 Vaginal P Livebirth LPS till 7 wks 78.7% LPS till PT+ve (4 wks) 82.4% Aboulghar 2008 Vaginal or IM P Miscarriage LPS till 10 wks 4.6% LPS till USS (7 wks) 4.8% Goudge 2010 IM P Livebirth LPS till 8 wks 52.0% LPS till PT+ve (4 wks) 49.0% Kyrou 2011 Vaginal P Ongoing LPS till 7 wks 82.0% LPS till PT+ve (4 wks) 73.0% Kohls 2012 Vaginal P Ongoing LPS till 8 wks 73.0% LPS till USS (5 wks) 75.0%
  • 45. Conclusion • Prevalence of a luteal phase defect in natural cycles is about 8.1% (Rosenberg et al., 1980). • In these cases LPS is controversial • CC stimulated cycles do not disturb the luteal phase, however there is an urgent need for prospective randomised trials. • HMG/rec-FSH with GnRH agonist and antagonist cycles must be supplemented.
  • 46. Conclusion • IVF ✓vaginal P alone for about 2 weeks from day of hCG, TUGOR or ET • FET in natural cycles ✓Controversial • IUI ✓Vaginal progesterone for 2 weeks
  • 47. Dr. Laxmi Shrikhande Shrikhande IVF & Surrogacy Center Ph-96234 59766 / shrikhandedrlaxmi@gmail.com
  • 48. 'Spiritual blossoming' simply means blossoming in life in all dimensions. Being happy, at ease with yourself and with everybody around you. Sri Sri Ravi Shankar The Art of Living